Moxieye-LP Gel is a unique, combination intraocular corticosteroid and antibiotic gel indicated for the treatment of postoperative inflammation and infection following cataract surgery or other ocular surgery in adults. The gel contains 0.5% w/v loteprednol etabonate, a potent intraocular corticosteroid, and 0.5% w/v moxifloxacin, a broad-spectrum antibiotic. This dual-action formulation targets both the inflammation and infection that can occur in the eye following surgery, providing a comprehensive therapeutic approach. Loteprednol etabonate reduces inflammation by inhibiting the production of arachidonic acid metabolites, while moxifloxacin inhibits bacterial protein synthesis, thereby preventing bacterial growth and replication. By combining these two active ingredients, Moxieye-LP Gel offers a synergistic effect in reducing the risk of complications and promoting a faster, more comfortable recovery for patients.